Dose-ranging Study of PRX-102 in Adult Fabry Disease Patients
Clinical trial NCT01678898 · COMPLETED
Trial details
- NCT number
- NCT01678898
- Sponsor
- Protalix
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2016-03-06
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.